HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma
- 10 June 2004
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 64 (1) , 84-87
- https://doi.org/10.1111/j.0001-2815.2004.00250.x
Abstract
The current study focuses the analysis on the possible relationship between HLA allele frequency and clinical outcome of melanoma in a population of 382 Italian patients, as compared with 203 ethnically matched controls. In a 3-year follow-up study, results showed significant differences between groups of patients selected according to clinical stage, histology, and progression of the disease. A*01 seems to be correlated with a less aggressive variant of the disease, whereas DRB1*01-DQB1*0501 seems to be associated with metastatic progression of melanoma. Moreover, a negative association with B*13, B*44, as well as with DRB1*04-DQB1*0302 was found. A multivariate logistic regression model showed HLA-DRB1*04 to behave as an independent favorable prognostic marker of melanoma in our population (OR = 2.34, CI = 1.15-4.74).Keywords
This publication has 23 references indexed in Scilit:
- Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotypeInternational Journal of Cancer, 2003
- Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancerInternational Journal of Cancer, 2003
- Multivariate Prognostic Model for Patients With Thick Cutaneous Melanoma: Importance of Sentinel Lymph Node StatusAnnals of Surgical Oncology, 2002
- Presence of the Human Leukocyte Antigen Class II Gene DRB1*1101 Predicts Interferon gamma Levels and Disease Recurrence in Melanoma PatientsAnnals of Surgical Oncology, 2002
- A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 moleculesTissue Antigens, 2000
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- HLA‐DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian populationTissue Antigens, 1998
- HLA‐DQB1*0301 association with increased cutaneous melanoma riskInternational Journal of Cancer, 1994
- Analysis of genes within the HLA region affecting susceptibility to ulcerative colitisHuman Immunology, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992